Table 5 The relationship between clinic-pathological characteristics and cancer specific survival in patients with primary operable invasive ductal breast cancer

0.97(0.64-1.45)

0.861

2.16(1.52-3.05)

<0.001

1.58(1.09-2.29)

0.014

1.84(1.31-2.57)

<0.001

1.43(1.00-2.05)

0.049

2.83(1.87-4.28)

<0.001

1.82(1.17-2.83)

0.008

0.59(0.39-0.89)

0.012

0.571

0.72(0.48-1.09)

0.128

1.34(0.84-2.14)

0.216

0.48(0.26-0.88)

0.018

0.114

1.56(1.05-2.33)

0.029

0.611

2.39(1.61-3.54)

<0.001

0.196

3.31(2.19-4.97)

<0.001

1.69(1.08-2.67)

0.023

5.12(3.38-7.78)

<0.001

3.35(2.21-5.63)

<0.001

0.69(0.36-1.36)

0.290

2.33(2.32-3.31)

0.007

1.93(1.04-3.59)

0.038

1.64(1.64-2.74)

0.061

0.184

0.75(0.38-1.45)

0.388

0.91(0.47-1.78)

0.780

2.11(1.03-4.31)

0.040

0.368

0.91(0.41-2.02)

0.822

0.83(0.39-1.72)

0.612

2.43(1.21-4.89)

0.010

0.649

3.24(1.67-6.29)

0.001

2.29(1.15-4.58)

0.004

6.03(2.87-13.77)

<0.001

4.43(2.07-9.51)

0.001

1.09(0.57-2.01)

0.784

3.43(2.01-5.85)

<0.001

2.94(1.65-5.24)

<0.001

0.79(0.39-1.58)

0.503

4.08(2.01-8.27)

<0.001

2.36(1.11-5.03)

0.026

0.89(0.27-2.89)

0.842

0.93(0.48-1.78)

0.824

2.31(1.21-4.42)

0.011

0.294

3.57(1.82-7.04)

<0.001

2.61(1.36-5.04)

0.014

4.68(3.09-10.31)

<0.001

3.63(1.38-6.56)

0.001